|View printer-friendly version|
|September 28, 2007 2:08 p.m.|
|Teva Announces Court Of Appeals Denies Novartis' Emergency Motion On Generic Famvir®|
Jerusalem, Israel, September 28, 2007 - Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA) announced today that further to its press release dated September 8, 2007, the United States Court of Appeals for the Federal Circuit has denied Novartis' emergency motion for an injunction pending its appeal of a September 5, 2007 District Court preliminary injunction ruling in favor of Teva. Teva can resume sales of its generic Famciclovir Tablets, AB-rated to Novartis' Famvir Tablets.